SCHEMBL5772229

SCHEMBL5772229

Clc1ccc(N2CCN(CCCc3[nH]nc4c3CCCC4)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.52
DRD2 P14416 12/20 0.49
DRD3 P35462 12/20 0.49
HTR1A P08908 8/20 0.49
HTR2A P28223 8/20 0.49
DRD1 P21728 7/20 0.49
TMEM97 Q5BJF2 4/20 0.49
DRD5 P21918 3/20 0.49
HTR2C P28335 5/20 0.48
HRH1 P35367 3/20 0.48
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
SLC6A4 P31645 3/20 0.46
HTR7 P34969 3/20 0.46
DRD4 P21917 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776696 0.99 SIGMAR1 (0.51) SIGMAR1DRD2DRD3HTR1AHTR2A
Hydrochloric Acid SCHEMBL5770744 0.97 SIGMAR1 (0.51) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL5775439 0.88 MAPT (0.45) SIGMAR1DRD2DRD3HRH1KDM4E
SCHEMBL5774541 0.88 HTR1A (0.49) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL5772832 0.88 SIGMAR1 (0.53) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL5774841 0.88 HTR7 (0.42) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL7960754 0.87 HTR1A (0.48) SIGMAR1DRD2DRD3HTR1AHTR2A
Hydrochloric Acid SCHEMBL5772589 0.87 HTR1A (0.48) SIGMAR1DRD2DRD3HTR1AHTR2A
SCHEMBL5775029 0.87 MAPT (0.44) SIGMAR1DRD2DRD3HRH1KDM4E
SCHEMBL5772457 0.87 SIGMAR1 (0.52) SIGMAR1DRD2DRD3HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP claimed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US claimed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP claimed
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP disclosed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed